Cempra, Inc. (CEMP)

[RUMe2]

I guess what I don't understand is that, the fda was aware of the liver injury signals at the conclusion of p2 (if I am not mistaken on this), and approved the trial to move on to p3.

It's not like this was a revelation that arose during the ad com, and the fda acted in real time to this "problem." Do I have that right, anyone?

And if I do have that right, I'm in agreement with whomever posted that the fda acted based on the roll call vote, which provided them cover to "cya" on what they believed was a difficult decision for them. And, had the vote been more in support of approval, these cowards would have fell in line, like good little bureacrats.

I think it's a Washington D.C. thing, where these politicians/bureaucrats care more about their jobs/salaries than making the right/courageous decision!